| (210) | Number of the EPO application | 18714635 |
| (220) | Filing date of the EPO application | 2018.01.16 |
| (80) | EPO patent specification publication (B) | EPB nr. 38/2024, 2024.09.18 |
| (110) | EPO patent number | 3570885 |
| (11) | Number of the document | MD 3570885 T2 |
| (21) | Number of the application | e 2019 1316 |
| (71) | Name(s) of applicant(s), code of the country | AMGEN INC., US; |
| (72) | Name(s) of inventor(s), code of the country | CHENG Yuan, US;
NETIROJJANAKUL Chawita, US;
HOLDER Jerry Ryan, US;
WU Bin, US;
FALSEY James R., US;
HERBERICH Bradley J., US;
SHAM Kelvin, US;
MIRANDA Leslie P., US;
LU Shu-Chen, US;
VENIANT-ELLISON Murielle M., US;
STANISLAUS Shanaka, US;
YIE Junming, US;
XU Jing, US; |
| (73) | Name(s) of owner(s), code of the country | AMGEN INC., US; |
| (54) | Title of the invention | Method of treating or ameliorating metabolic disorders using glp-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (gipr) |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 39/395 (2006.01.01); C07K 16/28 (2006.01.01); A61P 3/10 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2020.01.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2025.03.31 |
| (30) | Priority | 201762447332 P, 2017.01.17, US |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2018/013918, 2018.01.16 |
| (87) | International publication | WO 2018/136440, 2018.07.26 |